Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia

References

• EsteyEDohnerHAcute myeloid leukaemiaLancet200636895501894190717126723
   PubMed Web of Science ®Google Scholar
• LaneSWScaddenDTGillilandDGThe leukemic stem cell niche: current concepts and therapeutic opportunitiesBlood200911461150115719401558
   PubMed Web of Science ®Google Scholar
• HuntlyBJPGillilandDGCancer biology: summing up cancer stem cellsNature200543570461169117015988505
   PubMedGoogle Scholar
• JordanCTGuzmanMLNobleMCancer stem cellsN Engl J Med2006355121253126116990388
   PubMed Web of Science ®Google Scholar
• KirwanMVulliamyTMarroneADefining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemiaHum Mutat200930111567157319760749
   PubMed Web of Science ®Google Scholar
• SlovakMLKopeckyKJCassilethPAKaryotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group StudyBlood200096134075408311110676
   PubMed Web of Science ®Google Scholar
• ByrdJCMrozekKDodgeRKPretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)Blood2002100134325433612393746
   PubMed Web of Science ®Google Scholar
• NguyenTTMohrbacherAFTsaiYCQuantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: biological implicationsBlood20009592990299210779450
   PubMedGoogle Scholar
• JonesPABaylinSBThe fundamental role of epigenetic events in cancerNat Rev Genet20023641542812042769
   PubMed Web of Science ®Google Scholar
• EstellerMProfiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the icebergClin Immunol20031091808814585279
   PubMed Web of Science ®Google Scholar
• GalmOHermanJGBaylinSBThe fundamental role of epigenetics in hematopoietic malignanciesBlood Rev200620111316426940
   PubMed Web of Science ®Google Scholar
• KostromaIIGritsaevSVSidorovaZhYAberrant methylation of the promoter regions of the SOX7 and p15INK4b genes and Wnt signaling pathway antagonists in patients with acute myeloid leukemiasTer Arkh20168873136
   PubMedGoogle Scholar
• MikryukovAMossTAgonistic and antagonistic roles for TNIK and MINK in non-canonical and canonical Wnt signallingPLoS One201279e4333022984420
   PubMedGoogle Scholar
• KirstetterPAndersonKPorseBTJacobsenSENerlovCActivation of the canonial Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation blockNat Immunol20067101048105616951689
   PubMedGoogle Scholar
• XavierCPMelikovaMChumanYUrenABaljinnyamBRubinJSSecreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signalingCell Signal20142619410124080158
   PubMed Web of Science ®Google Scholar
• MalbonCCFrizzleds: new members of the superfamily of G-protein-coupled receptorsFront Biosci200491048105814977528
   PubMedGoogle Scholar
• WangHYMalbonCCWnt-Frizzled signaling to G-protein-coupled effectorsCell Mol Life Sci2004611697514704854
   PubMedGoogle Scholar
• KhanNIBendallLJRole of WNT signaling in normal and malignant hematopoiesisHistol Histopathol200621776177416598675
   PubMedGoogle Scholar
• StaalFJCleversHCWNT signalling and haematopoiesis: a WNT-WNT situationNat Rev Immunol200551213015630426
   PubMed Web of Science ®Google Scholar
• ReyaTDuncanAWAillesLA role for Wnt signalling in self-renewal of haematopoietic stem cellsNature2003423693840941412717450
   PubMed Web of Science ®Google Scholar
• RattisFMVoermansCReyaTWnt signaling in the stem cell nicheCurr Opin Hematol2004112889415257024
   PubMed Web of Science ®Google Scholar
• CleversHNusseRWnt/β-catenin signaling and diseaseCell201214961192120522682243
   PubMed Web of Science ®Google Scholar
• KohnoHAmatyaVJTakeshimaYAberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesotheliomaOncol Rep201024242343120596629
   PubMedGoogle Scholar
• GuoYGuoWChenZKuangGYangZDongZHypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinomaNeoplasma201158211011721275459
   PubMedGoogle Scholar
• ChimCSPangRFungTKChoiCLLiangREpigenetic dysregulation of Wnt signaling pathway in multiple myelomaLeukemia200721122527253617882284
   PubMedGoogle Scholar
• KimJTLiJJangERDeregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumorsCarcinogenesis201334595396123354304
   PubMedGoogle Scholar
• SuzukiHWatkinsDNJairKWEpigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancerNat Genet200436441742215034581
   PubMed Web of Science ®Google Scholar
• ValenciaARoman-GomezJCerveraJWnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemiaLeukemia20092391658166619387464
   PubMed Web of Science ®Google Scholar
• FigueroaMESkrabanekLLiYMDS and secondary AML display unique patterns and abundance of aberrant DNA methylationBlood2009114163448345819652201
   PubMed Web of Science ®Google Scholar
• JostESchmidJWilopSEpigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemiaBr J Haematol2008142574575318537968
   PubMedGoogle Scholar
• GriffithsEAGoreSDHookerCAcute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylationLeuk Lymphoma20105191711171920795789
   PubMed Web of Science ®Google Scholar
• BennettJMCatovskyDDanielMTProposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative GroupAnn Intern Med198510346206253862359
   PubMed Web of Science ®Google Scholar
• SwerdlowSHCampoEHarrisNLWHO Classification of Tumours of Haematopoietic and Lymphoid TissuesLyonIARC Press2008
   Google Scholar
• GrimwadeDHillsRKMoormanAVRefinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trialsBlood2010116335436520385793
   PubMed Web of Science ®Google Scholar
• YaoDMQianJLinJAberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemiaLeuk Res201135795796021106240
   PubMedGoogle Scholar
• GuoHLinJWenXMDecreased SFRP2 expression is associated with intermediate and poor karyotypes in de novo acute myeloid leukemiaInt J Clin Exp Pathol2014784695470325197341
   PubMedGoogle Scholar
• QianJZhuZHLinJHypomethylation of PRAME promoter is associated with poor prognosis in myelodysplastic syndromeBr J Haematol2011154115315521517806
   PubMedGoogle Scholar
• LinJYaoDMQianJRecurrent DNMT3A R882 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndromePLoS One2011610e2690622066015
   PubMed Web of Science ®Google Scholar
• LinJYaoDMQianJIDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndromeAnn Hematol201291451952521997850
   PubMed Web of Science ®Google Scholar
• YangXQianJSunARAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemiaClin Biochem2013467–857958323313659
   PubMed Web of Science ®Google Scholar
• WenXMLinJYangJDouble CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITDInt J Clin Exp Pathol20147106832684025400766
   PubMed Web of Science ®Google Scholar
• KottaridisPDGaleREFrewMEThe presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trialsBlood20019861752175911535508
   PubMed Web of Science ®Google Scholar
• GhasemiARostamiSChahardouliBAlizad GhandforoshNGhotaslouANadaliFStudy of SFRP1 and SFRP2 methylation status in patients with de novo acute myeloblastic leukemiaInt J Hematol Oncol Stem Cell Res201591152125802696
   PubMedGoogle Scholar
• ChengCKLiLChengSHSecreted-frizzled related protein 1 is a transcriptional repression target of the t(8;21) fusion protein in acute myeloid leukemiaBlood2011118256638664822031861
   PubMedGoogle Scholar
• ShenJZXuCBFuHYWuDSZhouHRFanLPMethylation of secreted frizzled related protein gene in acute leukemia patients in ChinaAsian Pac J Cancer Prev201112102617262122320963
   PubMedGoogle Scholar
• KristensenLSMikeskaTKrypuyMDobrovicASensitive Melting Analysis after Real Time-Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detectionNucleic Acids Res2008367e4218344521
   PubMed Web of Science ®Google Scholar
• CandiloroILMikeskaTDobrovicAAssessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylationEpigenetics20116450050721364322
   PubMed Web of Science ®Google Scholar
• TakedaMNagasakaTDong-ShengSExpansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesisActa Med Okayama201165316917721709714
   PubMedGoogle Scholar
• ReinsJMossnerMNeumannMTranscriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDSLeuk Res201034121610161620471677
   PubMedGoogle Scholar
• JostEGezerDWilopSEpigenetic dysregulation of secreted Frizzled-related proteins in multiple myelomaCancer Lett20092811243119299079
   PubMedGoogle Scholar